These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 26692078)

  • 21. Surgical strategy for local recurrence after resection of rectal cancer.
    Fujii S; Shimada H; Yamagishi S; Ota M; Ichikawa Y; Kunisaki C; Ike H; Ohki S
    Hepatogastroenterology; 2009; 56(91-92):667-71. PubMed ID: 19621677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment strategy for locally recurrent rectal cancer.
    Moriya Y
    Jpn J Clin Oncol; 2006 Mar; 36(3):127-31. PubMed ID: 16598032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery for locally recurrent rectal cancer.
    Boyle KM; Sagar PM; Chalmers AG; Sebag-Montefiore D; Cairns A; Eardley I
    Dis Colon Rectum; 2005 May; 48(5):929-37. PubMed ID: 15785880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure?: a single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 2010.
    Ghouti L; Pereira P; Filleron T; Humeau M; Guimbaud R; Selves J; Carrere N
    Am J Surg; 2015 Feb; 209(2):352-62. PubMed ID: 25524284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer.
    Wiig JN; Poulsen JP; Larsen S; Braendengen M; Waehre H; Giercksky KE
    Eur J Surg; 2002; 168(1):42-8. PubMed ID: 12022371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    PelvEx Collaborative
    Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
    Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
    Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results.
    Melton GB; Paty PB; Boland PJ; Healey JH; Savatta SG; Casas-Ganem JE; Guillem JG; Weiser MR; Cohen AM; Minsky BD; Wong WD; Temple LK
    Dis Colon Rectum; 2006 Aug; 49(8):1099-107. PubMed ID: 16779712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
    Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
    J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of surgical treatment of local and locoregional recurrence of rectal carcinoma--an analysis of 54 patients].
    Walz MK; Peitgen K; Meyer-Schwickerath M; Hoederath A; Eigler FW
    Zentralbl Chir; 1995; 120(3):236-42; discussion 243-4. PubMed ID: 7754726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
    Rottoli M; Vallicelli C; Boschi L; Poggioli G
    Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
    Platt E; Dovell G; Smolarek S
    Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
    Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
    Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
    Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
    Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer.
    Vermaas M; Ferenschild FT; Verhoef C; Nuyttens JJ; Marinelli AW; Wiggers T; Kirkels WJ; Eggermont AM; de Wilt JH
    Eur J Surg Oncol; 2007 May; 33(4):452-8. PubMed ID: 17071043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
    Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
    Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent.
    Bird TG; Ngan SY; Chu J; Kroon R; Lynch AC; Heriot AG
    Int J Colorectal Dis; 2018 Apr; 33(4):393-401. PubMed ID: 29468354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of survival following pelvic exenteration for primary rectal cancer.
    Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J;
    Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer.
    Yamada K; Ishizawa T; Niwa K; Chuman Y; Akiba S; Aikou T
    Br J Surg; 2001 Jul; 88(7):988-93. PubMed ID: 11442533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.